Safety Run-In and Phase II Trial of M7824 and Topotecan or Temozolomide in Relapsed Small Cell Cancers
Latest Information Update: 05 Feb 2024
At a glance
- Drugs Bintrafusp alfa (Primary) ; Temozolomide (Primary) ; Topotecan (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 27 Jan 2024 Planned primary completion date changed from 15 Jan 2024 to 15 Jan 2025.
- 23 Dec 2021 Status changed from suspended to recruiting.
- 19 Oct 2021 Status changed from recruiting to suspended.